Clinical Trials Browser

Phase 2 × Has results × Oncogenic osteomalacia × Clear all

NCT02304367 2024-05-06

Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)

Phase 2 Completed

17 enrolled 66 charts

Oncogenic osteomalacia, Nevus, Sebaceous of Jadassohn

NCT03510455 2021-04-08

BGJ398 for the Treatment of Tumor-Induced Osteomalacia

Phase 2 Terminated

4 enrolled 28 charts

Oncogenic osteomalacia, Hypophosphatemia